Merck KGaA (MRK)

Industry Drug Manufacturers - Specialty & Generic


This stock can be held in an Investment ISA and an Investment Account
Sell

Buy

arrow-up€ (+%)

Prices updated at 15 May 2025, 16:20
| Prices minimum 15 mins delay
|
Prices in EUR

Merck KGaA is a pharmaceutical and chemical company. It offers prescription medicines, diagnostics, and products used in allergen immunotherapy, specialty chemicals, and probiotic nutritional supplements.

Most recent dividend payment

2.200
Cash Dividend
28 Apr 2025
03 Feb 2025
29 Apr 2025
30 Apr 2025

Total dividend yield

Created with Highcharts 7.2.2Total yield (%)Total yield (%)2021202220232024202500.511.52

Dividend history and forecast data table

YearDividend per shareDividend growth (%)
20252.2000-
20242.2000-
20232.20000.19
20221.85000.32
20211.40000.08
20201.30000.04
20191.2500-
20181.25000.04
20171.20000.14
20161.05000.05

Total dividend yield data table

Dividend yield (%)Buyback yield (%)
20251.80-
20241.57-
20231.53-
20221.02-
20210.62-
20200.93-
20191.19-
20181.39-
20171.34-
20161.06-

Dividend per share

Created with Highcharts 7.2.2Dividend per shareDividend per share2021202220232024202500.511.522.5

% of earnings paid to shareholders

Created with Highcharts 7.2.2Payout ratio (%)Payout ratio (%)20212022202320242025010203040

Dividend per share data table

YearDividend per share
20252.2000
20242.2000
20232.2000
20221.8500
20211.4000
20201.3000
20191.2500
20181.2500
20171.2000
20161.0500

% of earnings paid to shareholders data table

YearPayout ratio (%)
202534.43
202435.54
202333.03
202223.15
202122.65
202029.95
201947.17
201827.53
201728.10
201630.79
Latest Financial Report as of 14 May 2025
Dividend amount and dividend per share are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.